whitepaper

Article: Multisystem inflammatory syndrome in children with COVID-19

Posted: 6 April 2021 | | No comments yet

Children with multisystem inflammatory syndrome have a unique immunological profile revealed by systems-level analyses.

A summary article of a recently published study in Cell. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) typically causes milder symptoms in children than in adults. But in rare cases, the virus can produce multisystem inflammatory syndrome in children (MIS-C) in association with coronavirus disease 19 (COVID-19). This severe condition usually manifests four to six weeks after infection, producing high fever, organ dysfunction, and strongly elevated markers of inflammation.












    To read this article in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Olink

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend